KR930701186A - 제조합 콜로니 자극 인자-1 용도 - Google Patents

제조합 콜로니 자극 인자-1 용도

Info

Publication number
KR930701186A
KR930701186A KR1019930700523A KR930700523A KR930701186A KR 930701186 A KR930701186 A KR 930701186A KR 1019930700523 A KR1019930700523 A KR 1019930700523A KR 930700523 A KR930700523 A KR 930700523A KR 930701186 A KR930701186 A KR 930701186A
Authority
KR
South Korea
Prior art keywords
stimulating factor
colony stimulating
manufacturing
csf
leukopenia
Prior art date
Application number
KR1019930700523A
Other languages
English (en)
Other versions
KR100234870B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR930701186A publication Critical patent/KR930701186A/ko
Application granted granted Critical
Publication of KR100234870B1 publication Critical patent/KR100234870B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019930700523A 1990-08-23 1991-08-23 제조합 콜로니 자극인자-1을 함유하는 약제학적 조성물 KR100234870B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57214990A 1990-08-23 1990-08-23
US7/572,149 1990-08-23
PCT/US1991/006052 WO1992003151A1 (en) 1990-08-23 1991-08-23 Uses of recombinant colony stimulating factor-1

Publications (2)

Publication Number Publication Date
KR930701186A true KR930701186A (ko) 1993-06-11
KR100234870B1 KR100234870B1 (ko) 1999-12-15

Family

ID=24286555

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930700523A KR100234870B1 (ko) 1990-08-23 1991-08-23 제조합 콜로니 자극인자-1을 함유하는 약제학적 조성물

Country Status (7)

Country Link
EP (2) EP0549702B1 (ko)
JP (3) JP3501801B2 (ko)
KR (1) KR100234870B1 (ko)
AT (1) ATE190497T1 (ko)
AU (1) AU646299B2 (ko)
DE (1) DE69132051D1 (ko)
WO (1) WO1992003151A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063372A (en) * 1995-10-27 2000-05-16 Inserm, Institut National De La Sante Et De La Recherche Medicale Uses of mammalian CTLA-8 and related reagents
AU7439996A (en) * 1995-10-27 1997-05-15 Institut National De La Sante Et De La Recherche Medicale Novel uses of mammalian ctla-8 and related reagents
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
RU2341296C2 (ru) 2002-05-24 2008-12-20 Энджиотек Интернэшнл Аг Композиции и способы покрытия медицинских имплантатов
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
WO2005070447A2 (en) * 2004-01-21 2005-08-04 Chiron Corporation M-csf muteins and uses thereof
GB0900786D0 (en) * 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
CN102648274B (zh) * 2009-12-09 2013-07-31 国立大学法人京都大学 包含双呋脒腙的促进多能干细胞分化成心肌细胞的组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE213950T1 (de) * 1987-09-22 2002-03-15 Chiron Corp Verwendung von rekombinantem koloniestimulierendem faktor-1 zur herstellung eines medikaments gegen cytomegalovirusinfektionen

Also Published As

Publication number Publication date
ATE190497T1 (de) 2000-04-15
JP3501801B2 (ja) 2004-03-02
AU646299B2 (en) 1994-02-17
JPH06500558A (ja) 1994-01-20
KR100234870B1 (ko) 1999-12-15
WO1992003151A1 (en) 1992-03-05
JP2003292454A (ja) 2003-10-15
JP2002275089A (ja) 2002-09-25
AU8647491A (en) 1992-03-17
EP0955056A1 (en) 1999-11-10
EP0549702B1 (en) 2000-03-15
EP0549702A1 (en) 1993-07-07
DE69132051D1 (de) 2000-04-20

Similar Documents

Publication Publication Date Title
FI864016A (fi) Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1.
ES2052580T3 (es) Nuevas formas de factor-1 estimulante de colonias.
DK174690D0 (da) Antibakterielle midler
DK0402068T3 (da) Polypeptider og polypeptidanaloger med inhiberende virkning mod human elastase
ATE218882T1 (de) Gleichzeitige verarbeitung von interleukin-3 mutanten und kolonie stimulierungsfactor
FI935585A (fi) Pyrrolopyrimidiinit
DK0442724T3 (da) Modificeret hIL-6.
ATE124959T1 (de) Herstellung und verwendung von nicht- glycosiliertem il-6.
BR8107293A (pt) Polipetidio anti-viral dna de duplo cordao veiculo de expressao plasmidico replicavel microorganismo transformado plasmidio processo de formacao do dito dna e do dito polipeptidio composicao farmaceutica e uso do dito polipeptidio
DE69206301D1 (de) Protein mit der Aktivität vom Typ von Cytokin, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.
KR930701186A (ko) 제조합 콜로니 자극 인자-1 용도
DK471386D0 (da) Farmaceutisk komposition til behandling af leukopeni
DE60228136D1 (de) Cytokin-proteinfamilie
DE3856516D1 (de) Verwendung von rekombinantem koloniestimulierendem Faktor-1 zur Herstellung eines Medikaments gegen Cytomegalovirusinfektionen
ES2039624T3 (es) Vectores de expresion para la produccion del factor estimulante de colonias de granulocitos macrofagos de seres humanos en una celula hospedante de mamifero.
DE69133140D1 (de) 2-Aryl-5-(trifluoromethyl)-2-pyrrolinderivate und Verfahren zur Herstellung von 2-Aryl-1-(alkoxymethyl)-4-halo-5-(trifluoromethyl)-pyrrolen mit insektizider Wirkung
CA2090121A1 (en) Uses of colony stimulating factor-1
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
ATE286509T1 (de) Interferon alpha/beta bindendes protein, seine herstellung und anwendung
CY1113344T1 (el) Χρηση της il-21 στον καρκινο και μονοκλωνικα αντισωματα για θεραπευτικη αγωγη στερεων καρκινων
ATE71656T1 (de) Fuer kolonie stimulierenden faktor kodierende dns, dadurch kodiertes peptid, diese dns enthaltende vektoren und transformierte wirte und herstellung derselben.
DK130292D0 (da) Rekombinant fremstillet, draebt adjuveret vaccine til brug i mink til profylakse mod parvovirus infektionen mink enteritis

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20080911

Year of fee payment: 10

LAPS Lapse due to unpaid annual fee